More on PLYX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:PLYX)
Delayed: 1.88 -0.07 (3.59%)
Prev. Close $1.95  
Open$1.92 
52 Wk High$ 
52 Wk Low$ 
Day High$2.03 
Day Low$1.87 
P/E N/A  
EPS$ 
Volume19,479 


Sep 14, 2026 06:02 AM Form 8-K Polaryx Therapeutics, For: Sep 10
Sep 1, 2026 08:30 AM Polaryx Therapeutics names Will Charlton as chief medical officer
Sep 1, 2026 08:30 AM Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
Aug 25, 2026 08:30 AM Polaryx targets Q4 2026 launch of SOTERIA Phase 2 trial
Aug 25, 2026 08:30 AM Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
Aug 13, 2026 04:17 PM Form 10-Q Polaryx Therapeutics, For: Jun 30
Aug 13, 2026 06:06 AM Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Jul 28, 2026 05:04 PM Form ARS Polaryx Therapeutics, For: Dec 31
Jul 28, 2026 05:02 PM Form DEFA14A Polaryx Therapeutics,
Jul 28, 2026 05:01 PM Form DEF 14A Polaryx Therapeutics, For: Sep 10
View All Articles

Entities mentioned with PLYX

View All Entities